KRAS Lung Cancer Explained: From "Undruggable" to Targetable with Dr. Fawzi Abu Rous | Pt 1/3

Mirrored EGFR template structure for KRAS podcast descriptionIn the premiere of our KRAS Biomarker Series, we're joined by Dr. Fawzi Abu Rous, a renowned thoracic medical oncologist at Henry Ford Cancer Institute, to demystify the biology of a KRAS positive diagnosis.For decades, KRAS was labeled "undruggable" the most common oncogenic driver in lung cancer, yet completely out of reach for targeted therapy. That changed when scientists discovered a hidden "pocket" on the G12C mutation, unlocking the first wave of KRAS inhibitors and rewriting what's possible for patients. Dr. Abu Rous walks us through how KRAS functions as a molecular "on/off switch" that gets jammed in the "on" position, why Comprehensive Biomarker Testing is non-negotiable, and what makes the KRAS landscape uniquely complex compared to other driver mutations.In this episode, we discuss:The "Jammed Switch": How a single amino acid swap flips KRAS into overdrive and drives uncontrolled cell growth.From "Undruggable" to Targetable: The decades-long puzzle and the G12C breakthrough that cracked it open.Reading the Genetic Address: Why G12C, G12D, G12V, and G13 mutations behave like different neighborhoods on the same street — and why each one matters.The Biomarker Testing Imperative: Why a complete molecular workup, not a partial panel, determines the path forward.Beyond the Stereotypes: Debunking assumptions about who gets KRAS-driven lung cancer and why young, never-smokers belong in this conversation too.This episode is proudly sponsored by Revolution Medicines.About Young Lung Cancer Initiative (YLCI) The YLCI is a 501(c)(3) nonprofit dedicated to the young-onset community. We provide support, research, and advocacy to ensure that no young person faces a lung cancer diagnosis alone.Disclaimer: This podcast is for informational purposes only and is not medical advice. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.